Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
30.64
-0.41 (-1.34%)
Apr 28, 2026, 12:07 PM EDT - Market open

HRMY Revenue

In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth. Harmony Biosciences Holdings had revenue of $243.78M in the quarter ending December 31, 2025, with 21.12% growth.

Revenue (ttm)
$868.45M
Revenue Growth
+21.51%
P/S Ratio
2.07
Revenue / Employee
$2,964,003
Employees
293
Market Cap
1.77B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025868.45M153.72M21.51%
Dec 31, 2024714.73M132.71M22.80%
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2,564.59%
Dec 31, 20196.00M--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Innoviva411.33M
Vericel276.26M
AnaptysBio234.60M
Recursion Pharmaceuticals74.68M
Nurix Therapeutics71.78M
Nuvation Bio62.90M
Taysha Gene Therapies9.77M
Revenue Rankings